Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI-Powered scans aim to predict breast cancer remission without surgery

NCT ID NCT06708910

First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 30 times

Summary

This study is testing whether a special PET/MRI scan, analyzed by artificial intelligence, can accurately tell if HER2-positive breast cancer has been completely eliminated by chemotherapy before surgery. Researchers will scan 460 women before, during, and after treatment, then compare the scan results to tissue samples taken during routine surgery. If successful, this approach could reduce the need for invasive procedures to confirm remission.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Diagnostic and Interventional Radiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

Conditions

Explore the condition pages connected to this study.